Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer
- 27 June 2007
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (3) , 224-227
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient settingDiseases of the Esophagus, 2006
- Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaOral Oncology, 2004
- A phase II study of single-agent docetaxel in patients with metastatic esophageal cancerAnnals of Oncology, 2004
- Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancerBritish Journal of Cancer, 2004
- Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalAnnals of Oncology, 2002
- Phase II Evaluation of Protracted Infusion of Cisplatin and 5-Fluorouracil in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407)Japanese Journal of Clinical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Chemotherapy in esophageal cancer.1999
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI: Journal of the National Cancer Institute, 1994
- Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassayCancer Chemotherapy and Pharmacology, 1991